evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
19635,GENE_BACKGROUND,,"The FLT4 (FMS-like tyrosine kinase 4) gene encodes vascular endothelial growth factor receptor 3 (VEGFR3), which plays a role in lymphangiogenesis and the maintenance the lymphatic endothelium (PMID: 10762646). Vascular endothelial growth factor (VEGF)-C signaling through FLT4 (VEGFR3) has been shown to mediate cell proliferation, survival and resistance to chemotherapy in leukemia (PMID: 11877295), and to promote invasion and metastasis of human lung adenocarcinoma cells (PMID: 16530705). Mutations in FLT4 cause hereditary Nonne-Milroy disease, an autosomal dominant form of primary lymphedema type IA (PMID: 11292664). In addition to its expression on lymphatic endothelial cells, FLT4 expression has been observed in lung adenocarcinoma (PMID: 12875690), colorectal adenocarcinoma (PMID: 12168824), head and neck carcinomas (PMID: 12784238), prostate carcinoma (PMID: 15701844), leukemia (PMID: 11877295), and Kaposi's sarcoma (PMID: 10068212). FLT4 expression levels were also shown to correlate with different stages of cervical carcinogenesis (PMID: 14648657). Few cancer-associated mutations in FLT4 have been reported.",,2017-04-07,,2324,FLT4,fms related tyrosine kinase 4,True,ENST00000261937,NM_182925.4,VEGFR3,FLT41,VEGFR-3,PCL,FLT-4,LMPH1A,False,11877295,"Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy.",Blood,2018-03-15T20:02:00,99,6,2179-84,Dias S et al,,,0001-03-15,,15701844,Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-01-15T20:05:00,11,2 Pt 1,584-93,Kaushal V et al,,,0001-01-15,,12784238,Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.,Head &amp; neck,2018-06-01T20:03:00,25,6,464-74,Neuchrist C et al,,,0001-06-01,,16530705,The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells.,Cancer cell,2018-03-01T20:06:00,9,3,209-23,Su JL et al,,,0001-03-01,,10068212,Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.,Laboratory investigation; a journal of technical methods and pathology,0001-02-01,79,2,243-51,Weninger W et al,,,0001-02-01,,10762646,Signaling pathways induced by vascular endothelial growth factor (review).,International journal of molecular medicine,2018-05-01T20:00:00,5,5,447-56,Larriv√©e B et al,,,0001-05-01,,11292664,"VEGFR3 gene structure, regulatory region, and sequence polymorphisms.",FASEB journal : official publication of the Federation of American Societies for Experimental Biology,2018-04-01T20:01:00,15,6,1028-36,Iljin K et al,,,0001-04-01,,12168824,Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma.,Anticancer research,2018-05-01T20:02:00,22,3,1463-6,Witte D et al,,,0001-05-01,,14648657,"Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis.",The Journal of pathology,2017-12-01T20:03:00,201,4,544-54,Van Trappen PO et al,,,0001-12-01,,12875690,Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer.,Chinese medical journal,2018-05-01T20:03:00,116,5,727-30,Li Q et al,,,0001-05-01,
19634,GENE_SUMMARY,,"FLT4 encodes a receptor tyrosine kinase involved in tumor angiogenesis. Point mutations, frameshift deletions or overexpression of FLT4 are found in colorectal, prostate and lung cancers, among others.",,2017-04-07,,2324,FLT4,fms related tyrosine kinase 4,True,ENST00000261937,NM_182925.4,VEGFR3,FLT41,VEGFR-3,PCL,FLT-4,LMPH1A,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
